|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Unrealized gain on marketable securities held in Trust Account | ||
| Excess fair value of private placement warrants over consideration paid | ||
| Change in fair value of warrant liabilities | ||
| Fair value of over allotment option liability | ||
| Change in fair value of overallotment option | ||
| Transaction costs allocable to liability instruments - warrants and over-allotment liabilities | ||
| Terminated merger transaction costs waived | ||
| Changes in operating assets and liabilities: | ||
| Prepaid insurance | ||
| Prepaid expense and other assets | ||
| Due from affiliate | ||
| Prepaid insurance – short term | ||
| Prepaid income taxes | ||
| Prepaid insurance – long term | ||
| Accounts payable and accrued expenses | ||
| Accrued terminated merger transaction costs | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investments and marketable securities held in trust | ||
| Cash withdrawn from Trust Account to pay franchise and income taxes | ||
| Net cash provided by (used in) investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from related party advances | ||
| Repayment of related party advances | ||
| Proceeds from sale of founder’s shares | ||
| Proceeds from sale of Units, net of offering costs | ||
| Proceeds from sales of Private Placement Warrants | ||
| Payment of underwriter’s discount | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash – Beginning of year | ||
| Cash – End of year | ||
| Non-Cash investing and financing activities: | ||
| Accretion for Class A common stock to redemption amount | ||
| Deferred underwriting fee payable | ||
| Forfeiture of private placement warrants |
Loading...
